| Literature DB >> 29404169 |
Abstract
Ranitidine is a well-tolerated H2-receptor antagonist commonly used in peptic ulcer treatment and stress ulcer prophylaxis. Anaphylaxis is rarely observed with ranitidine. We report the case of a patient who developed anaphylaxis after intravenous injection of ranitidine for acute COPD exacerbation. This article underlines the importance of awareness that in COPD acute exacerbation treatment, ranitidine, which is usually administered with methylprednisolone, also has anaphylaxis potential.Entities:
Keywords: Drug allergy; anaphylaxis; ranitidine
Year: 2017 PMID: 29404169 PMCID: PMC5783089 DOI: 10.5152/TurkThoracJ.2017.17002
Source DB: PubMed Journal: Turk Thorac J ISSN: 2148-7197